SPHK1 and melanoma: Imbert et al. showed that SK1 knockdown in melanoma tumors reduced the production of immunosuppressive cytokines (TGF-β, IL10, CCL17, and CCL22) and decreased Tregs tumor infiltration, while its inhibition significantly sensitized melanoma to immune checkpoint inhibitors treatment [53].